Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-027314
Filing Date
2023-05-04
Accepted
2023-05-04 16:03:53
Documents
1
Period of Report
2023-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 7208
  Complete submission text file 0001209191-23-027314.txt   8603
Mailing Address C/O ARDEA BIOSCIENCES INC 2131 PALOMAR AIRPORT ROAD SUITE 300 CARLSBAD CA 92011
Business Address
Krueger Christopher W (Reporting) CIK: 0001394208 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40928 | Film No.: 23888541

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations